KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 3 filers reported holding KRYSTAL BIOTECH INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,395,805 | +5.7% | 520,637 | +7.0% | 0.02% | +11.1% |
Q2 2023 | $57,124,745 | +54.4% | 486,597 | +5.3% | 0.02% | +50.0% |
Q1 2023 | $36,994,210 | +119851.4% | 462,090 | +18.7% | 0.01% | +33.3% |
Q4 2022 | $30,841 | -99.9% | 389,285 | +8.5% | 0.01% | -10.0% |
Q3 2022 | $25,012,000 | +38.1% | 358,837 | +30.0% | 0.01% | +66.7% |
Q2 2022 | $18,116,000 | +3.7% | 275,923 | +5.1% | 0.01% | +20.0% |
Q1 2022 | $17,465,000 | +65.7% | 262,463 | +74.2% | 0.01% | +66.7% |
Q4 2021 | $10,538,000 | +23.2% | 150,641 | -8.1% | 0.00% | 0.0% |
Q3 2021 | $8,557,000 | -41.1% | 163,864 | -23.3% | 0.00% | -40.0% |
Q2 2021 | $14,533,000 | +29.9% | 213,712 | +47.1% | 0.01% | +25.0% |
Q1 2021 | $11,192,000 | +172.9% | 145,332 | +112.6% | 0.00% | +300.0% |
Q4 2020 | $4,101,000 | +103.0% | 68,344 | +45.6% | 0.00% | 0.0% |
Q3 2020 | $2,020,000 | +36.0% | 46,954 | +30.9% | 0.00% | 0.0% |
Q2 2020 | $1,485,000 | +199.4% | 35,858 | +151.3% | 0.00% | – |
Q3 2019 | $496,000 | – | 14,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
Artal Group S.A. | 412,082 | $32,991 | 1.96% |
First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |